News

Precision medicine is providing new hope for patients with ovarian cancer, the most common cause of death from gynaecological cancers. Only 3 out of every 10 women diagnosed with advanced stage ovarian cancer will survive after five years. These statistics haven’t improved in 30 years, but precision medicine approaches are opening up new possibilities. While…  Read more

Hudson Institute researchers are closer to understanding the fundamental processes that make embryos develop as male, helping the 1 in 5000 babies that are born intersex.…  Read more

Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

A study led by Professor Vincent Harley and Dr Daniel Bird examining the genetic causes of intersex, where a person is born with characteristics that are not clearly male or female…  Read more

A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

PhD student, Aidan Kashyap has been selected as a FameLab semi-finalist for his research that is offering hope for babies who struggle to breathe at birth due to underdeveloped lungs. Aidan will compete against 11 other STEM early career researchers in the FameLab Victorian semi-finals at the Melbourne Museum on Wednesday, 28 March 2018. FameLab,…  Read more

The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more

Jasmine started experiencing severe period pain as a teenager and endured five years of pain before she was diagnosed with endometriosis. Her journey continues.…  Read more

High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM…  Read more

‘Invisible illness’ took years of pain and a trip to the emergency ward before diagnosis. It wasn’t until Evelyn’s debilitating symptoms started to impact her daily life that she sought help – but that was only the beginning of her journey.…  Read more